Sinzinger H, Gisslinger H, Linkesch W, Peskar B A
Atheroskleroseforschungsgruppe (ASF) Wien.
Wien Klin Wochenschr. 1990 Feb 2;102(3):74-6.
Patients with the myeloproliferative syndrome (MPS) often show morphological and functional platelet abnormalities and an increased incidence of lowered cyclooxygenase- and/or lipoxygenase activity. We present the case history of a 68-year-old male patient with polycythaemia vera in whom an absolute absence of platelet lipoxygenase activity has been detected for the first time in the literature.
骨髓增殖综合征（MPS）患者常表现出形态学和功能性血小板异常，以及环氧化酶和/或脂氧合酶活性降低的发生率增加。我们报告一例68岁真性红细胞增多症男性患者的病例史，该患者首次在文献中被检测到完全缺乏血小板脂氧合酶活性。
